MobbleOpen in Mobble ⇢
Health · Drug development · published 2026-10-07 · via Endpoints News

Biohub's virtual cell project reaches $1.8B with backing from Meta and Google

Mark Zuckerberg and Priscilla Chan's nonprofit Biohub is expanding an initiative to create AI models that predict how cells behave and other biological processes. The effort now has $1.8 billion in funding from technology companies and US government agencies. Meta and Google are among the supporters.

Expanded Detail

The Chan Zuckerberg Biohub, a nonprofit led by Mark Zuckerberg and Priscilla Chan, is broadening a project to build virtual cell models. The work uses artificial intelligence to forecast how cells act and how other biological processes unfold.

The initiative has now drawn $1.8 billion in support. That funding comes from technology companies and U.S. government agencies, with Meta and Google among the backers. The project’s scale is tied to support from both industry and federal sources.

Context

If virtual cell models mature, they could speed drug discovery and reduce some lab testing, potentially benefiting patients, researchers, and biotech firms. But reliance on AI predictions may raise questions about validation, data quality, and equitable access to resulting therapies. Tech and government funders may shape research priorities. These are possibilities, not certainties.

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at Endpoints News →
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “Zuckerberg's Biohub expands virtual cell effort to $1.8B, with Meta, Google.” Browse more stories.